Caren Sourij

623 total citations
30 papers, 265 citations indexed

About

Caren Sourij is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Caren Sourij has authored 30 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 6 papers in Physiology. Recurrent topics in Caren Sourij's work include Diabetes Management and Research (12 papers), Diabetes Treatment and Management (7 papers) and Pancreatic function and diabetes (7 papers). Caren Sourij is often cited by papers focused on Diabetes Management and Research (12 papers), Diabetes Treatment and Management (7 papers) and Pancreatic function and diabetes (7 papers). Caren Sourij collaborates with scholars based in Austria, Germany and United Kingdom. Caren Sourij's co-authors include Harald Sourij, Felix Aberer, Peter N. Pferschy, Harald Kojzar, Faisal Aziz, Norbert J. Tripolt, Othmar Moser, Max L. Eckstein, Thomas R. Pieber and Alexander Müller and has published in prestigious journals such as PLoS ONE, Diabetes Care and International Journal of Molecular Sciences.

In The Last Decade

Caren Sourij

27 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caren Sourij Austria 10 146 90 72 57 33 30 265
Peter N. Pferschy Austria 11 182 1.2× 113 1.3× 80 1.1× 61 1.1× 55 1.7× 27 307
Christophe Kosinski Switzerland 7 142 1.0× 192 2.1× 42 0.6× 24 0.4× 55 1.7× 21 315
DR Owens United Kingdom 7 112 0.8× 44 0.5× 44 0.6× 51 0.9× 57 1.7× 22 271
Vardit Gepstein Israel 8 55 0.4× 46 0.5× 19 0.3× 58 1.0× 33 1.0× 17 312
Н. И. Волкова Russia 7 80 0.5× 35 0.4× 27 0.4× 15 0.3× 25 0.8× 66 169
Harald Kojzar Austria 12 478 3.3× 94 1.0× 360 5.0× 287 5.0× 30 0.9× 33 570
Victoria Mendoza‐Zubieta Mexico 9 133 0.9× 22 0.2× 34 0.5× 20 0.4× 30 0.9× 29 220
Cem Sulu Türkiye 7 100 0.7× 84 0.9× 54 0.8× 18 0.3× 34 1.0× 39 267
Osemwegie Emovon United States 9 57 0.4× 30 0.3× 80 1.1× 43 0.8× 48 1.5× 21 313
Philippe Oriot Belgium 10 188 1.3× 31 0.3× 89 1.2× 67 1.2× 52 1.6× 31 273

Countries citing papers authored by Caren Sourij

Since Specialization
Citations

This map shows the geographic impact of Caren Sourij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caren Sourij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caren Sourij more than expected).

Fields of papers citing papers by Caren Sourij

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caren Sourij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caren Sourij. The network helps show where Caren Sourij may publish in the future.

Co-authorship network of co-authors of Caren Sourij

This figure shows the co-authorship network connecting the top 25 collaborators of Caren Sourij. A scholar is included among the top collaborators of Caren Sourij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caren Sourij. Caren Sourij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sourij, Caren, Martin Stradner, Peter Schlenke, et al.. (2025). IL‐10‐ and IL‐13‐Biased T Cell Responses to SARS‐CoV‐2 Vaccination in Diabetes. European Journal of Immunology. 55(12). e70112–e70112.
3.
Sourij, Caren, Faisal Aziz, Harald Kojzar, et al.. (2025). Prevalence of Undiagnosed Diabetes and Prediabetes according to Age and Obesity Status in Central Europe. Obesity Facts. 18(6). 582–591. 1 indexed citations
5.
Lewinski, Friederike von, Franz Quehenberger, Michael Sacherer, et al.. (2024). Air Pollution and Myocardial Infarction—A New Smoker’s Paradox?. Journal of Clinical Medicine. 13(23). 7324–7324. 1 indexed citations
7.
Paar, Margret, Gerhard Cvirn, Gilbert Reibnegger, et al.. (2023). Albumin of People with Diabetes Mellitus Is More Reduced at Low HbA1c. International Journal of Molecular Sciences. 24(22). 16256–16256. 2 indexed citations
8.
Sourij, Caren, Faisal Aziz, Harald Kojzar, et al.. (2023). Changes in Lipoprotein(a) Levels in People after ST Elevation Myocardial Infarction—The STEMI-Lipids Study. International Journal of Molecular Sciences. 24(21). 15531–15531. 4 indexed citations
9.
Schweighofer, Natascha, et al.. (2023). Identification of Novel Intronic SNPs in Transporter Genes Associated with Metformin Side Effects. Genes. 14(8). 1609–1609. 2 indexed citations
10.
11.
Sourij, Caren, Faisal Aziz, Norbert J. Tripolt, et al.. (2023). Effects of empagliflozin in women and men with acute myocardial infarction: An analysis from the EMMY trial. Hellenic Journal of Cardiology. 75. 3–8. 7 indexed citations
12.
Eyileten, Ceren, Zofia Wicik, Faisal Aziz, et al.. (2022). Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study. Cardiovascular Diabetology. 21(1). 79–79. 15 indexed citations
13.
Moser, Othmar, Alexander Müller, Felix Aberer, et al.. (2022). Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study). Diabetes Technology & Therapeutics. 25(3). 161–168. 7 indexed citations
14.
Tripolt, Norbert J., Peter N. Pferschy, Harald Kojzar, et al.. (2022). Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial. Diabetes Care. 46(2). 463–468. 51 indexed citations
15.
Moser, Othmar, Max L. Eckstein, Alexander Mueller, et al.. (2021). Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes – A Cross-Over Controlled Trial. Frontiers in Endocrinology. 12. 656346–656346. 9 indexed citations
16.
Aberer, Felix, Othmar Moser, Faisal Aziz, et al.. (2021). Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study. Diabetes Care. 45(2). e24–e26. 20 indexed citations
17.
Aziz, Faisal, Felix Aberer, Othmar Moser, et al.. (2021). Impact of comorbidities on mortality in hospitalized influenza patients with diabetes – Analysis of the Austrian Health Insurance. Diabetes Research and Clinical Practice. 174. 108758–108758. 6 indexed citations
19.
Aberer, Felix, Peter N. Pferschy, Norbert J. Tripolt, et al.. (2019). Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study. Diabetes Obesity and Metabolism. 22(2). 212–221. 10 indexed citations
20.
Tripolt, Norbert J., Felix Aberer, Jasmin Url, et al.. (2018). Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial. Diabetes Therapy. 10(1). 299–309. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026